How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

487 results for

Superficial Thrombophlebitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Medical eligibility criteria for contraceptive use

to “superficial venous disorders”. The subcondition “superficial thrombophlebitis” has been changed to “superficial venous thrombosis” (SVT). Question 1: Among women with varicose veins, does use of combined hormonal contraceptives (CHCs) increase the risk of venous thromboembolism (VTE) or superficial venous thrombosis (SVT) compared with non-use of CHCs? (Direct evidence) Selection criteria for the systematic review Study design Randomized controlled trials, cohort studies and case-control studies (...) contraceptives among breastfeeding women 28 Recommendations for combined hormonal contraceptives among postpartum women 34 Recommendations for combined hormonal contraceptives among women with superficial venous disorders 38 Recommendations for combined hormonal contraceptives among women with dyslipidaemias 42 Recommendations for progestogen-only contraceptives and levonorgestrel-releasing intrauterine devices among breastfeeding women 47 Recommendations for safety of depot medroxyprogesterone acetate

2015 World Health Organisation Guidelines

102. Xeljanz (tofacitinib citrate)

or blood vessels in tissues. In 4816 subjects treated with tofacitinib in Japanese and foreign clinical studies in RA patients, 10 vasculitis, phlebitis, thrombophlebitis, superficial thrombophlebitis, rheumatoid vasculitis, and cutaneous vasculitis (1-4 subjects each) as events classified as vasculitis, thrombosis, venous thrombosis, deep vein thrombosis, limb venous thrombosis, coronary artery thrombosis, and subclavian vein thrombosis (9 subjects had deep vein thrombosis, 1-3 subjects each

2013 Pharmaceuticals and Medical Devices Agency, Japan

103. Trends in knee arthroscopy utilization: a gap in knowledge translation. (Abstract)

on the meniscectomy cohort, average patient age significantly increased from 47.9 ± 15.1 to 50.7 ± 13.5 (p = 0.001). The overall incidence of complications was 2.0% (n = 1333), with major complications in 0.9% (n = 639) and minor complications in 1.0% (n = 701). Common complications included a return to the operating room (0.5%), deep vein thrombosis/thrombophlebitis (0.4%), and superficial infection (0.2%). Operating time > 90 min, diabetes, steroid use, ASA class 2+, and dialysis-dependency were the predictors

2019 Knee Surgery, Sports Traumatology, Arthroscopy

104. A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis. Full Text available with Trip Pro

A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU/ml) compared to heparin topical gel (200 IU/g) in prevention of infusion-associated phlebitis. Thrombosis and thrombophlebitis of the superficial venous system are common in hospitalized patients. Efficacy and safety of topical quick penetrating solution (QPS) of heparin were compared to heparin sodium topical gel for the prevention of infusion-associated phlebitis.Patients aged 18-65 years

2019 Indian journal of pharmacology Controlled trial quality: uncertain

105. Thromboinflammation: Challenges of Therapeutically Targeting Coagulation and other Host Defence Mechanisms. Full Text available with Trip Pro

Thromboinflammation: Challenges of Therapeutically Targeting Coagulation and other Host Defence Mechanisms. Thrombosis with associated inflammation (thromboinflammation) occurs commonly in a broad range of human disorders. It is well recognized clinically in the context of superficial thrombophlebitis (thrombosis and inflammation of superficial veins); however, it is more dangerous when it develops in the microvasculature of injured tissues and organs. Microvascular thrombosis with associated

2019 Blood

106. A 49-year-old with chest pain and bioprosthetic aortic valve. (Abstract)

A 49-year-old with chest pain and bioprosthetic aortic valve. Which of the following diagnoses best explains this presentation?Iatrogenic left main stem ostial stenosisSaddle pulmonary embolismMondor's syndrome (thrombophlebitis of superficial veins of chest wall)Coronary thromboembolismEpicardial fat necrosis.© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

2019 Heart

109. Boils, carbuncles, and staphylococcal carriage

and carbuncles include: Scarring [ ]. Spread of infection such as cellulitis; thrombophlebitis; and less commonly, septic arthritis, osteomyelitis, endocarditis, sepsis, and brain abscess [ ; ]. Systemic reactions, such as staphylococcal scalded-skin syndrome [ ]. Cavernous sinus thrombosis — this is rare, and can result from boils or carbuncles on the lips, nose or cheek [ ]. Staphylococcal carriage Staphylococcal carriage Definition What is staphylococcal carriage? Staphylococcal carriage (or colonization (...) become inflamed and tender intermittently and discharge pus. Folliculitis — a superficial infection of the hair follicles, which develop into small inflammatory papules or pustules. Hidradenitis suppurativa — a chronic inflammatory suppurative disease of the apocrine sweat glands causing painful, inflamed nodules and sterile abscesses. Consider this if only the groin and the axillae are involved. Rare conditions that may resemble a boil or carbuncle include: Anthrax — can resemble a carbuncle

2017 NICE Clinical Knowledge Summaries

110. Compression stockings

of compression (class of stocking) used should depend on the condition being treated. It should be the highest the person can tolerate. Varicose veins — class 1 or 2 stockings, depending on the severity. Venous eczema, lipodermatosclerosis, atrophie blanche, healed venous leg ulcers — class 2 stockings, or class 3 stockings if inadequate response to class 2 stockings, or class 1 if class 2 is not tolerated. Superficial thrombophlebitis — class 2 stockings, however most people find class 2 stockings too (...) not offer elastic graduated compression stockings to prevent post-thrombotic syndrome or venous thromboembolism (VTE) recurrence after a proximal DVT. This recommendation does not cover the use of elastic stockings for the management of leg symptoms after DVT. For more information, see the CKS topic on . Superficial thrombophlebitis — class 2 stockings. Most people find class 2 stockings too painful, class 1 stockings or travel socks are practical alternatives. For more information, see the CKS topic

2017 NICE Clinical Knowledge Summaries

112. ChampioNIR® SFA Stent EFS Study

limiting claudication or rest pain (Rutherford-Becker scale 2-4) with a resting ankle-brachial index/toe-brachial index (ABI/TBI) <0.90/0.80. A single superficial femoral artery lesion with >50% stenosis or total occlusion. Stenotic lesion(s) or occluded length within the same vessel (one long or multiple serial lesions) ≥ 40 mm to ≤ 140 mm. Reference vessel diameter (RVD) ≥ 3.0 mm and ≤ 6.0 mm by visual assessment. Target lesion located with the distal point at least 3 cm above the knee joint, defined (...) and tests and are able and willing to provide informed consent. Exclusion Criteria: Thrombophlebitis or deep venous thrombus, within the previous 30 days. Presence of thrombus in the treated vessel as visualized by angiography, prior to crossing the lesion. Thrombolysis of the target vessel within 72 hours prior to the index procedure, where complete resolution of the thrombus was not achieved. Poor aortoiliac or common femoral "inflow" (i.e. angiographically defined >50% stenosis of the iliac or common

2018 Clinical Trials

113. Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions

surgery prior to randomization. Subject with history of cerebrovascular accident (including ischemic, embolic, and hemorrhagic cerebrovascular accident), transient ischemic attack, deep venous thrombosis (DVT; including proximal and distal), pulmonary or arterial embolism, arterial thrombosis or other venous thrombosis within 6 months prior to randomization Note: prior superficial thrombophlebitis is not an exclusion criterion. New-onset seizures or poorly controlled seizures within 12 weeks prior

2018 Clinical Trials

114. Evaluation of the Efficacy and Tolerability of Detralex Treatment in Patients With Chronic Venous Edema (CEAP Class С3) in Real Clinical Practice

of the following concomitant diseases, which can affect the results: Connective tissue disease (including rheumatoid arthritis), arthritis Heart failure Intermittent claudication (peripheral artery disease) Diseases of the bones or joints of the lower extremities Malignancy Treatment with drugs potentially causing leg edema (calcium channel blockers, hormonal drugs, NSAIDs, etc.) History of deep vein thrombosis (within the past year) History of superficial thrombophlebitis (within the past 3 months) Patient

2018 Clinical Trials

115. Mondor’s disease – a rare cause of chest pain: a case report Full Text available with Trip Pro

Mondor’s disease – a rare cause of chest pain: a case report Chest pain is one of the common presenting symptoms encountered in an emergency department. Prompt history taking and careful clinical examination do help to differentiate cardiac chest pain from other causes. Mondor's disease is a rare cause of chest pain which is often underdiagnosed due to lack of awareness. Mondor's disease is a condition characterized by thrombophlebitis of the superficial veins of breast and anterior chest (...) wall. The diagnosis is often made clinically.Here we report a case of a 37-year-old Sri Lankan Tamil woman who presented with chest pain and was clinically diagnosed as having Mondor's disease after a physical examination, which was confirmed with demonstration of thrombophlebitis by ultrasound scan imaging. Although it is a self-limiting condition, non-steroidal anti-inflammatory drugs are used in the treatment to hasten recovery in addition to giving reassurance.Mondor's disease is not considered

2018 Journal of medical case reports

116. What Is Vascular Behçet’s Disease? Full Text available with Trip Pro

are follows; saccular aneurysms without atherosclerosis developed in younger than 50-year-old patients, superior vena cava syndrome or deep vein thrombosis in bilateral legs without apparent causes, and multiple superficial thrombophlebitis, etc. It is very difficult to make a diagnosis of BD in the patients whose onset of the disease is a vascular lesion, because vascular BD combines few ocular lesions. In such case, it is very important to find out not only oral and genital ulceration, but also past

2018 Annals of vascular diseases

117. Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients

with higher scores representing worse outcome. One point is added to a baseline score of 0 for each of the following: indwelling venous material, localized pain, unilateral pitting edema. One point is subtracted for another diagnosis being at least as plausible as venous thrombosis. Secondary Outcome Measures : Development of catheter related local phlebitis or superficial thrombophlebitis [ Time Frame: While the catheter is in place, an average of two weeks ] Phlebitis as defined by a Visual Infusion (...) the IV site; 5- All of the following: Pain, erythema, palpable venous cord and fever >38 degrees centigrade. Thrombophlebitis is defined by phlebitis associated with superficial thrombosis as detected by ultrasound or venogram. Central line associated blood stream infection (CLABSI) [ Time Frame: While the catheter is in place, an average of two weeks ] The study definition for CLABSI follows the Centers for Disease Control guidelines Number of participants with catheter associated deep venous

2018 Clinical Trials

118. Evaluation of Cirvoâ„¢ Mobile Compression Device for Treatment of Venous Leg Ulcers

documented by venous reflex ultrasound showing mild, moderate, or severe reflux in the superficial or deep venous system Exclusion Criteria: Acute DVT within the 3 months prior to enrollment Ulcer present for <2 weeks Ulcers extending with exposed fascia, tendon, or bone within the wound margins Lateral malleolus ulcers Ulcers with perforator incompetence deep to the ulceration (within 5 cm of the wound border) Active infection (systemic or in the affected limb) Lower extremity gangrene Diabetes mellitus (...) (Type I or II) requiring medication History of pulmonary vascular disease (PVD) History of pulmonary edema History of decompensated congestive heart failure (CHF) Open surgery or major trauma to the legs within the last six months History of lower limb malignancy, primary or secondary Acute symptomatic lower extremity thrombophlebitis Pregnant or breastfeeding Calf geometry on which Cirvo(TM) device does not appropriately fit Known sensitivity to any of the materials used in the Cirvo(TM) device

2018 Clinical Trials

119. Effects of Functional Electrical Stimulation in Patients Undergoing Coronary Artery Bypass Grafting Surgery

the survey Chronic respiratory diseases Hemodynamic instability Orthopedic and neurological diseases that may preclude the achievement of the cardiopulmonary test and Cardiac Rehabilitation exercises Psychological and/or cognitive impairment that restrict them to respond to questionnaires Changes of skin sensitivity,skin lesion and allergic skin problems Severe lymphedema Uncontrolled diabetes mellitus Acute superficial venous thrombophlebitis Systemic arterial hypertension Contacts and Locations Go

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>